Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy.
Cao, Wen-Ming; Pan, Jiani; Wang, Xiaojia; Lou, Feng; Li, Mingwei; Wang, Meng; Wang, Rong; Ye, Weiwu
刊名JOURNAL OF CLINICAL ONCOLOGY
2022-06-01
卷号40
ISSN号0732-183X
WOS研究方向Oncology
语种英语
出版者LIPPINCOTT WILLIAMS & WILKINS
WOS记录号WOS:000863680302671
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129899]  
专题中国科学院合肥物质科学研究院
作者单位1.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Breast Med Oncol, Hangzhou, Peoples R China
2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Dept Breast Med Oncol, Canc Hosp, Hangzhou, Peoples R China
3.Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China
5.AcornMed Biotechnol Co Ltd, Beijing, Peoples R China
6.Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Cao, Wen-Ming,Pan, Jiani,Wang, Xiaojia,et al. Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA Cao, Wen-Ming.,Pan, Jiani.,Wang, Xiaojia.,Lou, Feng.,Li, Mingwei.,...&Ye, Weiwu.(2022).Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy..JOURNAL OF CLINICAL ONCOLOGY,40.
MLA Cao, Wen-Ming,et al."Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy.".JOURNAL OF CLINICAL ONCOLOGY 40(2022).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace